Cargando…

Follow-Up of Celiac Disease in Adults: “When, What, Who, and Where”

For patients with celiac disease (CeD), a lifelong gluten-free diet is not a voluntary lifestyle choice—it is a necessity. The key end points in clinical follow-up are symptom resolution, the normalization of weight, prevention of overweight, seroconversion, and negation or minimization of increased...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulder, Chris J. J., Elli, Luca, Lebwohl, Benjamin, Makharia, Govind K., Rostami, Kamran, Rubio-Tapia, Alberto, Schumann, Michael, Tye-Din, Jason, Zeitz, Jonas, Al-Toma, Abdulbaqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181343/ https://www.ncbi.nlm.nih.gov/pubmed/37432208 http://dx.doi.org/10.3390/nu15092048

Ejemplares similares

Who to screen and how to screen for celiac disease
por: Singh, Prashant, et al.
Publicado: (2022)

Celiac Disease
por: Makharia, Govind K., et al.
Publicado: (2012)

Current and Emerging Therapy for Celiac Disease
por: Makharia, Govind K.
Publicado: (2014)

Evolving Therapy for Celiac Disease
por: Yoosuf, Shakira, et al.
Publicado: (2019)

The Dietary and Non-Dietary Management of Osteoporosis in Adult-Onset Celiac Disease: Current Status and Practical Guidance
por: Al-Toma, Abdulbaqi, et al.
Publicado: (2022)

A13 THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSS-SECTIONAL STUDY
por: Tandon, S, et al.
Publicado: (2023)

The Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical Dilemma
por: Makharia, Archita, et al.
Publicado: (2015)

Non-Invasive Biomarkers for Celiac Disease
por: Singh, Alka, et al.
Publicado: (2019)

Problems and Challenges to Adaptation of Gluten Free Diet by Indian Patients with Celiac Disease
por: Rajpoot, Preeti, et al.
Publicado: (2013)

Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis
por: Ashtari, Sara, et al.
Publicado: (2021)

Opportunities and challenges in the management of celiac disease in Asia
por: Agarwal, Ashish, et al.
Publicado: (2020)

Celiac disease and non-celiac gluten sensitivity
por: Lebwohl, Benjamin, et al.
Publicado: (2015)

Emergence of Celiac Disease and Gluten-related Disorders in Asia
por: Mohta, Srikant, et al.
Publicado: (2021)

Who, when, where, how!
Publicado: (1960)

Collaborative Web Search: Who, What, Where, When, and Why
por: Morris, Meredith Ringel, et al.
Publicado: (2009)

Liver complications in celiac disease
por: Zali, Mohammad Reza, et al.
Publicado: (2011)

Subclinical celiac disease and gluten sensitivity
por: Nejad, Mohammad Rostami, et al.
Publicado: (2011)

Hepatitis B Vaccination Reliability in Celiac Disease
por: Rostami Nejad, Mohammad, et al.
Publicado: (2011)

Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
por: Sandhu, Vaneet K, et al.
Publicado: (2022)

Gluten-Free Diet in Co-Existent Celiac Disease and Type 1 Diabetes Mellitus: Is It Detrimental or Beneficial to Glycemic Control, Vascular Complications, and Quality of Life?
por: Eland, Ingo, et al.
Publicado: (2022)

Gluten-Free Diet in Celiac Disease—Forever and for All?
por: Itzlinger, Alice, et al.
Publicado: (2018)

A simple phenotypic classification for celiac disease
por: Sood, Ajit, et al.
Publicado: (2018)

When Women Deliver with No One Present in Nigeria: Who, What, Where and So What?
por: Fapohunda, Bolaji M., et al.
Publicado: (2013)

Borrelia infection and risk of celiac disease
por: Alaedini, Armin, et al.
Publicado: (2017)

Transplanting Cells for Spinal Cord Repair: Who, What, When, Where and Why?
por: Zholudeva, Lyandysha V., et al.
Publicado: (2019)

The Crucial Questions on Synovial Biopsy: When, Why, Who, What, Where, and How?
por: Ingegnoli, Francesca, et al.
Publicado: (2021)

Navigating the who, where, what, when, how and why of trauma exposure and response
por: Vallières, Frédérique, et al.
Publicado: (2021)

Aiming for the end of the COVID-19 pandemic: the what, how, who, where, and when
por: Soriano, Joan B., et al.
Publicado: (2023)

Genomic prediction of celiac disease targeting HLA-positive individuals
por: Abraham, Gad, et al.
Publicado: (2015)

Gene–Environment Studies: Who, How, When, and Where?
por: Spivey, Angela
Publicado: (2006)

Seronegative coeliac disease: Are they coeliac? When biopsy in adult can be avoided?
por: Rostami, Kamran, et al.
Publicado: (2018)

Mesenchymal stem cells as potential therapeutic approaches in celiac disease
por: Moheb-Alian, Ali, et al.
Publicado: (2016)

Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies
por: Tye-Din, Jason A., et al.
Publicado: (2018)

Psychotropic medication use among patients with celiac disease
por: Zylberberg, Haley M., et al.
Publicado: (2018)

Palliative care in intensive care units: why, where, what, who, when, how
por: Mercadante, Sebastiano, et al.
Publicado: (2018)

An analysis of funding patterns in development assistance for mental health: who, when, what, and where
por: Gribble, Rebecca S. F., et al.
Publicado: (2021)

Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
por: Derkay, Craig S., et al.
Publicado: (2022)

COVID-19 and celiac disease: a review
por: Cohen, Brandon S., et al.
Publicado: (2023)

Human Leukocyte Antigen DQ (HLA‐DQ) genotypes and haplotypes and their association with phenotype in patients with celiac disease in India
por: Ramakrishna, Balakrishnan S, et al.
Publicado: (2021)

Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
por: Agarwal, Ashish, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bh4e7fg7fpc3ru45f14egog85q